Early Neurodevelopmental Outcomes in Pediatric Congenital Heart Disease - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Early Neurodevelopmental Outcomes in Pediatric Congenital Heart Disease

In a multicenter registry study, genetic diagnoses were associated with substantially lower cognitive, language, and motor scores; while birth weight, surgical timing, hospitalization burden, and caregiver education were also associated with outcomes.

  • By

  • Andrea Surnit

  • June 2, 2026

  • 3 min

Share

  • 1

    Pediatric patients with congenital heart disease and a genetic diagnosis have lower cognitive, language, and motor scores compared to those without a genetic diagnosis.

  • 2

    A study analyzed 942 neurodevelopmental assessments from patients under 30 months who underwent cardiac surgery requiring cardiopulmonary bypass.

  • 3

    Patients with trisomy 21 had the lowest scores, followed by those with 22q11.2 deletion syndrome and other genetic conditions.

  • 4

    Clinical factors like lower birth weight, male sex, and caregiver education level were associated with poorer neurodevelopmental outcomes.

  • 5

    The study highlights the need for ongoing surveillance of neurodevelopmental outcomes in infants undergoing heart surgery.

Original Source(s)

Early Neurodevelopmental Outcomes in Pediatric Congenital Heart Disease

  • by Andrea Surnit

  • June 2, 2026

Related Content

Baptist Health Heart & Vascular Care to Host 43rd Annual Echocardiography and Structural Heart Symposium

Baptist Health South Florida will host the Baptist Health Heart & Vascular Care 43rd Annual Echocardiography and Structural Heart Symposium on Oct. 2-3 at the Loews Coral Gables Hotel.

  • by

  • August 28, 2026

  • 4 min
Menopause may be underdocumented in EHRs

Surveys captured nearly 7 times as many menopause observations as structured clinical records, with high agreement when both sources identified menopause.

Enterovirus diversity may limit treatment advances

Research highlights expanding diagnostic capabilities but persistent gaps in antiviral therapy and vaccine coverage for pediatric enterovirus infections.